Mano Horinaka
8PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 13, 2026
Discovery of a Novel γ-Glutamylcyclotransferase Inhibitor Plumbagin by Luminescence-Based High-Throughput Screening.Keiko Taniguchi, Yukie Nohara, Mano Horinaka
|May 29, 2025
Combination Therapy of Avutometinib and MRTX1133 Synergistically Suppresses Cell Growth by Inducing Apoptosis in KRASG12D-Mutated Pancreatic Cancer.Ema Toyokuni, Mano Horinaka, Emi Nishimoto
|Nov 04, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers.Yuki Katayama, Tadaaki Yamada, Keiko Tanimura
|Jul 23, 2024
Initial AXL and MCL-1 inhibition contributes to abolishing lazertinib tolerance in EGFR-mutant lung cancer cells.Yohei Matsui, Tadaaki Yamada, Yuki Katayama
|May 31, 2024
Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer.Akihiro Yoshimura, Mano Horinaka, Takeshi Yaoi
Pageof 2
Frequent Collaborators
4 joint publications
Tadaaki Yamada
4 joint publications
Toshiyuki Sakai
3 joint publications
Koichi Takayama
3 joint publications
Soichi Hirai
3 joint publications
Masaki Ishida
3 joint publications
Yohei Matsui
3 joint publications
Ryota Nakamura
2 joint publications
Yuki Katayama
2 joint publications
Hayato Kawachi
2 joint publications
Kenji Morimoto